Benedict Fallet
Basel, BS 4009, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.
Journal: The Journal of infection
Published: April 02, 2023
Vaccine-elicited CD4 T cells prevent the deletion of antiviral B cells in chronic infection.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 29, 2021
Behçet's-like adverse event or inaugural Behçet's disease after SARS-CoV-2 mRNA-1273 vaccination?
Journal: Rheumatology (Oxford, England)
Published: July 30, 2021
Vectored antibody gene delivery restores host B and T cell control of persistent viral infection.
Journal: Cell reports
Published: April 29, 2021
COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions
Journal: Revue medicale suisse
Published: April 08, 2021
Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies.
Journal: Expert review of clinical pharmacology
Published: October 03, 2020
Mild Course of COVID-19 and Spontaneous Virus Clearance in a Patient With Depleted Peripheral Blood B Cells Due to Rituximab Treatment.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 28, 2020
Chronic Viral Infection Promotes Efficient Germinal Center B Cell Responses.
Journal: Cell reports
Published: June 24, 2019
Interferon-γ-Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever.
Journal: Cell host & microbe
Published: February 13, 2017
Interferon-driven deletion of antiviral B cells at the onset of chronic infection.
Journal: Science immunology
Published: November 23, 2016
Inflammatory monocytes hinder antiviral B cell responses.
Journal: Science immunology
Published: November 22, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026